{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:17:40Z","timestamp":1788175060315,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong","doi-asserted-by":"publisher","award":["2022BCE040"],"award-info":[{"award-number":["2022BCE040"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Biomedical Research Foundation, Hubei University of Medicine","award":["PI201804"],"award-info":[{"award-number":["PI201804"]}]},{"name":"the Open Project of Hubei Key Laboratory of Wudang Local Chinese Medicine Research","award":["WDCM2023020"],"award-info":[{"award-number":["WDCM2023020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s10787-023-01396-6","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T15:02:35Z","timestamp":1705417355000},"page":"849-861","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Baricitinib relieves DSS-induced ulcerative colitis in mice by suppressing the NF-\u03baB and JAK2\/STAT3 signalling pathways"],"prefix":"10.1007","volume":"32","author":[{"given":"Qiong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmeiqi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyu","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4763-0072","authenticated-orcid":false,"given":"Yang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"issue":"12","key":"1396_CR1","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.2174\/13894501113146660224","volume":"14","author":"M Allocca","year":"2013","unstructured":"Allocca M, Jovani M, Fiorino G et al (2013) Anti-IL-6 treatment for inflammatory bowel diseases: next cytokine, next target. Curr Drug Targets 14(12):1508\u20131521. https:\/\/doi.org\/10.2174\/13894501113146660224","journal-title":"Curr Drug Targets"},{"issue":"2","key":"1396_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00011-003-1219-z","volume":"53","author":"P Ashwood","year":"2004","unstructured":"Ashwood P, Harvey R, Verjee T et al (2004) Functional interactions between mucosal IL-1, IL-ra and TGF-beta 1 in ulcerative colitis. Inflamm Res 53(2):53\u201359. https:\/\/doi.org\/10.1007\/s00011-003-1219-z","journal-title":"Inflamm Res"},{"issue":"3","key":"1396_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1385\/CRIAI:28:3:187","volume":"28","author":"R Atreya","year":"2005","unstructured":"Atreya R, Neurath MF (2005) Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin Rev Allergy Immunol 28(3):187\u2013196. https:\/\/doi.org\/10.1385\/CRIAI:28:3:187","journal-title":"Clin Rev Allergy Immunol"},{"issue":"10","key":"1396_CR4","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1093\/rheumatology\/keac068","volume":"61","author":"A Barbulescu","year":"2022","unstructured":"Barbulescu A, Askling J, Chatzidionysiou K et al (2022) Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register data. Rheumatology (oxford) 61(10):3952\u20133962. https:\/\/doi.org\/10.1093\/rheumatology\/keac068","journal-title":"Rheumatology (oxford)"},{"issue":"15","key":"1396_CR5","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","volume":"336","author":"PJ Barnes","year":"1997","unstructured":"Barnes PJ, Karin M (1997) Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336(15):1066\u20131071. https:\/\/doi.org\/10.1056\/NEJM199704103361506","journal-title":"N Engl J Med"},{"issue":"7","key":"1396_CR6","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1053\/j.gastro.2006.03.022","volume":"130","author":"B Begue","year":"2006","unstructured":"Begue B, Wajant H, Bambou JC et al (2006) Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions. Gastroenterology 130(7):1962\u20131974. https:\/\/doi.org\/10.1053\/j.gastro.2006.03.022","journal-title":"Gastroenterology"},{"key":"1396_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2013.06.007","volume":"76","author":"M Coskun","year":"2013","unstructured":"Coskun M, Salem M, Pedersen J, Nielsen OH (2013) Involvement of JAK\/STAT signaling in the pathogenesis of inflammatory bowel disease. Pharmacol Res 76:1\u20138. https:\/\/doi.org\/10.1016\/j.phrs.2013.06.007","journal-title":"Pharmacol Res"},{"issue":"5","key":"1396_CR8","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1053\/j.gastro.2019.01.002","volume":"156","author":"S Coward","year":"2019","unstructured":"Coward S, Clement F, Benchimol EI et al (2019) Past and future burden of inflammatory bowel diseases based on modeling of population-based data. Gastroenterology 156(5):1345-1353.e4. https:\/\/doi.org\/10.1053\/j.gastro.2019.01.002","journal-title":"Gastroenterology"},{"key":"1396_CR9","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.ijbiomac.2020.10.259","volume":"166","author":"L Cui","year":"2021","unstructured":"Cui L, Guan X, Ding W et al (2021) Scutellaria baicalensis Georgi polysaccharide ameliorates DSS-induced ulcerative colitis by improving intestinal barrier function and modulating gut microbiota. Int J Biol Macromol 166:1035\u20131045. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.10.259","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"1396_CR10","doi-asserted-by":"publisher","first-page":"G155","DOI":"10.1152\/ajpgi.00311.2015","volume":"310","author":"S Danese","year":"2016","unstructured":"Danese S, Grisham M, Hodge J, Telliez JB (2016) JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines. Am J Physiol Gastrointest Liver Physiol 310(3):G155\u2013G162. https:\/\/doi.org\/10.1152\/ajpgi.00311.2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5","key":"1396_CR11","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","volume":"146","author":"EV Dang","year":"2011","unstructured":"Dang EV, Barbi J, Yang HY et al (2011) Control of T(H)17\/T(reg) balance by hypoxia-inducible factor 1. Cell 146(5):772\u2013784. https:\/\/doi.org\/10.1016\/j.cell.2011.07.033","journal-title":"Cell"},{"issue":"11","key":"1396_CR12","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1002\/mc.22691","volume":"56","author":"X Fang","year":"2017","unstructured":"Fang X, Hong Y, Dai L et al (2017) CRH promotes human colon cancer cell proliferation via IL-6\/JAK2\/STAT3 signaling pathway and VEGF-induced tumor angiogenesis. Mol Carcinog 56(11):2434\u20132445. https:\/\/doi.org\/10.1002\/mc.22691","journal-title":"Mol Carcinog"},{"issue":"13","key":"1396_CR13","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1084\/jem.20061341","volume":"203","author":"J Lohr","year":"2006","unstructured":"Lohr J, Knoechel B, Wang JJ et al (2006) Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J Exp Med 203(13):2785\u20132791. https:\/\/doi.org\/10.1084\/jem.20061341","journal-title":"J Exp Med"},{"issue":"Suppl 8","key":"1396_CR14","first-page":"56","volume":"30","author":"Y Murata","year":"1995","unstructured":"Murata Y, Ishiguro Y, Itoh J et al (1995) The role of proinflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis. J Gastroenterol 30(Suppl 8):56\u201360","journal-title":"J Gastroenterol"},{"issue":"3","key":"1396_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.103017","volume":"21","author":"H Nakase","year":"2022","unstructured":"Nakase H, Sato N, Mizuno N, Ikawa Y (2022) The influence of cytokines on the complex pathology of ulcerative colitis. Autoimmun Rev 21(3):103017. https:\/\/doi.org\/10.1016\/j.autrev.2021.103017","journal-title":"Autoimmun Rev"},{"issue":"5","key":"1396_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nri3661","volume":"14","author":"MF Neurath","year":"2014","unstructured":"Neurath MF (2014) Cytokines in inflammatory bowel disease. Nat Rev Immunol 14(5):329\u2013342. https:\/\/doi.org\/10.1038\/nri3661","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"1396_CR17","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.immuni.2012.03.014","volume":"36","author":"JJ O'Shea","year":"2012","unstructured":"O\u2019Shea JJ, Plenge R (2012) JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 36(4):542\u2013550. https:\/\/doi.org\/10.1016\/j.immuni.2012.03.014","journal-title":"Immunity"},{"issue":"2","key":"1396_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJMra1202117","volume":"368","author":"JJ O'Shea","year":"2013","unstructured":"O\u2019Shea JJ, Holland SM, Staudt LM (2013) JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl J Med 368(2):161\u2013170. https:\/\/doi.org\/10.1056\/NEJMra1202117","journal-title":"N Engl J Med"},{"issue":"5","key":"1396_CR19","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.cell.2019.07.045","volume":"178","author":"DR Plichta","year":"2019","unstructured":"Plichta DR, Graham DB, Subramanian S, Xavier RJ (2019) Therapeutic opportunities in inflammatory bowel disease: mechanistic dissection of host-microbiome relationships. Cell 178(5):1041\u20131056. https:\/\/doi.org\/10.1016\/j.cell.2019.07.045","journal-title":"Cell"},{"issue":"3","key":"1396_CR20","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/BF01540912","volume":"16","author":"JM Reimund","year":"1996","unstructured":"Reimund JM, Wittersheim C, Dumont S et al (1996) Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn\u2019s disease. J Clin Immunol 16(3):144\u2013150. https:\/\/doi.org\/10.1007\/BF01540912","journal-title":"J Clin Immunol"},{"issue":"2","key":"1396_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.7861\/clinmed.2021-0080","volume":"21","author":"JP Segal","year":"2021","unstructured":"Segal JP, LeBlanc JF, Hart AL (2021) Ulcerative colitis: an update. Clin Med (lond) 21(2):135\u2013139. https:\/\/doi.org\/10.7861\/clinmed.2021-0080","journal-title":"Clin Med (lond)"},{"issue":"6","key":"1396_CR22","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1053\/j.gastro.2011.02.016","volume":"140","author":"W Strober","year":"2011","unstructured":"Strober W, Fuss IJ (2011) Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140(6):1756\u20131767. https:\/\/doi.org\/10.1053\/j.gastro.2011.02.016","journal-title":"Gastroenterology"},{"key":"1396_CR23","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3389\/fphar.2018.00746","volume":"9","author":"JH Tao","year":"2018","unstructured":"Tao JH, Duan JA, Zhang W et al (2018) Polysaccharides from chrysanthemum morifolium ramat ameliorate colitis rats via regulation of the metabolic profiling and NF-\u03ba B\/TLR4 and IL-6\/JAK2\/STAT3 signaling pathways. Front Pharmacol 9:746. https:\/\/doi.org\/10.3389\/fphar.2018.00746","journal-title":"Front Pharmacol"},{"issue":"3","key":"1396_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1136\/annrheumdis-2021-221276","volume":"81","author":"PC Taylor","year":"2022","unstructured":"Taylor PC, Takeuchi T, Burmester GR et al (2022) Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database. Ann Rheum Dis 81(3):335\u2013343. https:\/\/doi.org\/10.1136\/annrheumdis-2021-221276","journal-title":"Ann Rheum Dis"},{"key":"1396_CR25","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.biopha.2016.11.061","volume":"85","author":"H Wang","year":"2017","unstructured":"Wang H, Gu J, Hou X et al (2017) Anti-inflammatory effect of miltirone on inflammatory bowel disease via TLR4\/NF-\u03baB\/IQGAP2 signaling pathway. Biomed Pharmacother 85:531\u2013540. https:\/\/doi.org\/10.1016\/j.biopha.2016.11.061","journal-title":"Biomed Pharmacother"},{"key":"1396_CR26","doi-asserted-by":"publisher","first-page":"8813558","DOI":"10.1155\/2020\/8813558","volume":"2020","author":"JB Yan","year":"2020","unstructured":"Yan JB, Luo MM, Chen ZY, He BH (2020) The function and role of the Th17\/Treg cell balance in inflammatory bowel disease. J Immunol Res 2020:8813558. https:\/\/doi.org\/10.1155\/2020\/8813558","journal-title":"J Immunol Res"},{"issue":"2","key":"1396_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017164","volume":"6","author":"J Yang","year":"2011","unstructured":"Yang J, Yang X, Chu Y, Li M (2011) Identification of Baicalin as an immunoregulatory compound by controlling T(H)17 cell differentiation. PLoS\u00a0One 6(2):e17164. https:\/\/doi.org\/10.1371\/journal.pone.0017164","journal-title":"PLoS\u00a0One"},{"issue":"7829","key":"1396_CR28","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2799-2","volume":"586","author":"M Zhang","year":"2020","unstructured":"Zhang M, Zhou L, Xu Y et al (2020) A STAT3 palmitoylation cycle promotes TH17 differentiation and colitis. Nature 586(7829):434\u2013439. https:\/\/doi.org\/10.1038\/s41586-020-2799-2","journal-title":"Nature"},{"issue":"47","key":"1396_CR29","doi-asserted-by":"publisher","first-page":"14192","DOI":"10.1021\/acs.jafc.1c05839","volume":"69","author":"L Zhang","year":"2021","unstructured":"Zhang L, Yao X, Ma M et al (2021) Protective Effect of l-Theanine against DSS-Induced Colitis by Regulating the Lipid Metabolism and Reducing Inflammation via the NF-\u03baB Signaling Pathway. J Agric Food Chem 69(47):14192\u201314203. https:\/\/doi.org\/10.1021\/acs.jafc.1c05839","journal-title":"J Agric Food Chem"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01396-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-023-01396-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01396-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T02:50:31Z","timestamp":1709347831000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-023-01396-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1396"],"URL":"https:\/\/doi.org\/10.1007\/s10787-023-01396-6","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,16]]},"assertion":[{"value":"1 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal studies were conducted according to protocols approved by the Hubei University of Medicine Animal Care and Use Committee (Approval No: 2022068), complying with the rules of Regulations for the Administration of Affairs Concerning Experimental Animals (approved by the State Council of China).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}